467.165 USD
-2.32 (-0.5%)
Last: Feb 2, 2026, 12:52 PM
Overall UTHR gets a fundamental rating of 7 out of 10. We evaluated UTHR against 524 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making UTHR a very profitable company, without any liquidiy or solvency issues. UTHR has a correct valuation and a medium growth rate. This makes UTHR very considerable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year UTHR was profitable.
- In the past year UTHR had a positive cash flow from operations.
- Each year in the past 5 years UTHR has been profitable.
- Each year in the past 5 years UTHR had a positive operating cash flow.
1.2 Ratios
- UTHR has a better Return On Assets (17.30%) than 95.99% of its industry peers.
- UTHR's Return On Equity of 19.30% is amongst the best of the industry. UTHR outperforms 95.61% of its industry peers.
- UTHR's Return On Invested Capital of 17.33% is amongst the best of the industry. UTHR outperforms 96.95% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for UTHR is below the industry average of 18.07%.
- The 3 year average ROIC (14.96%) for UTHR is below the current ROIC(17.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.3% | ||
| ROE | 19.3% | ||
| ROIC | 17.33% |
ROA(3y)14%
ROA(5y)12.47%
ROE(3y)16.72%
ROE(5y)15.47%
ROIC(3y)14.96%
ROIC(5y)13.31%
1.3 Margins
- The Profit Margin of UTHR (40.65%) is better than 97.14% of its industry peers.
- In the last couple of years the Profit Margin of UTHR has grown nicely.
- With an excellent Operating Margin value of 48.65%, UTHR belongs to the best of the industry, outperforming 99.62% of the companies in the same industry.
- In the last couple of years the Operating Margin of UTHR has grown nicely.
- UTHR has a better Gross Margin (88.59%) than 90.65% of its industry peers.
- UTHR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 48.65% | ||
| PM (TTM) | 40.65% | ||
| GM | 88.59% |
OM growth 3Y7.2%
OM growth 5Y2.85%
PM growth 3Y13.74%
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
- UTHR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- UTHR has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, UTHR has more shares outstanding
- Compared to 1 year ago, UTHR has an improved debt to assets ratio.
2.2 Solvency
- UTHR has an Altman-Z score of 19.09. This indicates that UTHR is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of UTHR (19.09) is better than 89.31% of its industry peers.
- UTHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 19.09 |
ROIC/WACC1.96
WACC8.84%
2.3 Liquidity
- UTHR has a Current Ratio of 6.40. This indicates that UTHR is financially healthy and has no problem in meeting its short term obligations.
- With a decent Current ratio value of 6.40, UTHR is doing good in the industry, outperforming 65.27% of the companies in the same industry.
- A Quick Ratio of 6.07 indicates that UTHR has no problem at all paying its short term obligations.
- With a decent Quick ratio value of 6.07, UTHR is doing good in the industry, outperforming 64.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.4 | ||
| Quick Ratio | 6.07 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 15.90% over the past year.
- The Earnings Per Share has been growing by 16.88% on average over the past years. This is quite good.
- Looking at the last year, UTHR shows a quite strong growth in Revenue. The Revenue has grown by 13.50% in the last year.
- Measured over the past years, UTHR shows a quite strong growth in Revenue. The Revenue has been growing by 14.71% on average per year.
EPS 1Y (TTM)15.9%
EPS 3Y34.86%
EPS 5Y16.88%
EPS Q2Q%12.05%
Revenue 1Y (TTM)13.5%
Revenue growth 3Y19.52%
Revenue growth 5Y14.71%
Sales Q2Q%6.76%
3.2 Future
- The Earnings Per Share is expected to grow by 11.57% on average over the next years. This is quite good.
- UTHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.21% yearly.
EPS Next Y12.48%
EPS Next 2Y9.45%
EPS Next 3Y8.97%
EPS Next 5Y11.57%
Revenue Next Year11.46%
Revenue Next 2Y8.55%
Revenue Next 3Y9.27%
Revenue Next 5Y11.21%
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 17.70, UTHR is valued on the expensive side.
- Based on the Price/Earnings ratio, UTHR is valued cheaply inside the industry as 95.04% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 28.32, UTHR is valued a bit cheaper.
- A Price/Forward Earnings ratio of 15.85 indicates a correct valuation of UTHR.
- Based on the Price/Forward Earnings ratio, UTHR is valued cheaply inside the industry as 95.23% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.57, UTHR is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.7 | ||
| Fwd PE | 15.85 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UTHR indicates a rather cheap valuation: UTHR is cheaper than 97.33% of the companies listed in the same industry.
- UTHR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. UTHR is cheaper than 95.99% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.02 | ||
| EV/EBITDA | 9.99 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of UTHR may justify a higher PE ratio.
PEG (NY)1.42
PEG (5Y)1.05
EPS Next 2Y9.45%
EPS Next 3Y8.97%
5. Dividend
5.1 Amount
- UTHR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
UNITED THERAPEUTICS CORP / UTHR FAQ
What is the fundamental rating for UTHR stock?
ChartMill assigns a fundamental rating of 7 / 10 to UTHR.
What is the valuation status of UNITED THERAPEUTICS CORP (UTHR) stock?
ChartMill assigns a valuation rating of 6 / 10 to UNITED THERAPEUTICS CORP (UTHR). This can be considered as Fairly Valued.
Can you provide the profitability details for UNITED THERAPEUTICS CORP?
UNITED THERAPEUTICS CORP (UTHR) has a profitability rating of 9 / 10.
What are the PE and PB ratios of UNITED THERAPEUTICS CORP (UTHR) stock?
The Price/Earnings (PE) ratio for UNITED THERAPEUTICS CORP (UTHR) is 17.7 and the Price/Book (PB) ratio is 3.05.
What is the expected EPS growth for UNITED THERAPEUTICS CORP (UTHR) stock?
The Earnings per Share (EPS) of UNITED THERAPEUTICS CORP (UTHR) is expected to grow by 12.48% in the next year.